CONTACT US
Home > Inhibitors/Agonists> > Fabomotizole
Fabomotizole

Fabomotizole

  • CAT Number: I002257
  • CAS Number: 173352-21-1
  • Molecular Formula: C15H21N3O2S
  • Molecular Weight: 307.41
  • Purity: ≥95%
Inquiry Now

<p style=/line-height:25px/>Fabomotizole is an anxiolytic drug; produces anxiolytic and neuroprotective effects without any sedative or muscle relaxant actions.<br>IC50 value:<br>Target: anxiolytic agent<br>Afobazole/’s mechanism of action remains poorly defined however, with GABAergic, NGF and BDNF release promoting, MT1 receptor antagonism, MT3 receptor antagonism, and sigma agonism suggested as potential mechanisms. Afobazole was shown to inhibit MAO-A reversibly and there might be also some involvement with serotonin receptors. Afobazole has found little clinical use outside of Russia and has not been evaluated by the FDA.</p>

Catalog Number I002257
CAS Number 173352-21-1
Molecular Formula

C15H21N3O2S

Purity 95%
Target anxiolytic agent
Solubility 10 mM in DMSO
Storage Store at -20°C
InChI InChI=1S/C15H21N3O2S/c1-2-20-12-3-4-13-14(11-12)17-15(16-13)21-10-7-18-5-8-19-9-6-18/h3-4,11H,2,5-10H2,1H3,(H,16,17)
InChIKey WWNUCVSRRUDYPP-UHFFFAOYSA-N
SMILES CCOC1=CC=C2C(N=C(SCCN3CCOCC3)N2)=C1
Reference

<p style=/line-height:25px/>
<br>[1]. Afobazole, From Wikipedia
</p>

Request a Quote

Contact Us at MuseChem

We are committed to providing you with reliable, cost-effective solutions for your chemical needs, while ensuring your safety and comfort. Our team of experts is always available to answer your questions and help you navigate the complexities of the chemical industry.

Whether you're looking for a specific product or need help with a custom synthesis project, we're here to help you discover a new world of chemical possibilities. Contact us today to learn more about how we can assist you with all of your chemical needs.

Our goal is to make the process of ordering chemicals as seamless and hassle-free as possible. Let us know how we can assist you, and we'll get back to you as soon as possible. We look forward to hearing from you!